IDV vehicle
36F79724D0190
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC FEDERAL SUPPLY SCHEDULE (36F797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $2.6M |
| Start date | Sep 1, 2024 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Aug 21, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 21, 2026 | P00009 | $0 | SUBCONTRACTING PLAN INCORPORATION (2026-07-01 TO 2027-06-30) |
| Jun 15, 2026 | P00008 | $0 | PRODUCT ADDITION - INFLUENZA VACCINES | 2 NDCS - 70461-0026-03 & 70461-0656-03 |
| Feb 9, 2026 | P00007 | $0 | PRODUCT DELETION | 5 NDCS (33332-0024-03, 33332-0124-10, 70461-0024-03, 70461-0554-10 & 70461-0654-03) - INFLUENZA VACCINES |
| Dec 5, 2025 | P00006 | $0 | LIFECYCLE CYCLE CHANGES (PROVISIONAL TO PERMANENT) | INFLUENZA VACCINES (3 NDCS) |
| Sep 4, 2025 | P00005 | $0 | 2025-2026 SUBK PLAN INCORPORATION (07-01-2025 TO 06-30-2026) |
| Aug 22, 2025 | P00003 | $0 | PRODUCT ADDITION (3 NDCS-INFLUENZA) |
| May 30, 2025 | P00004 | $0 | SAF UPDATE (DATED: 05-06-2025) |
| Nov 14, 2024 | P00002 | $0 | LIFE CYCLE CHANGES MODIFICATION |
| Oct 15, 2024 | P00001 | $0 | DELETION OF 5 NDCS |
| Aug 23, 2024 | 0 | $0 | 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.